| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Characteristics | 38 | 2024 | 2621 | 5.460 |
Why?
|
| Schizophrenia | 95 | 2023 | 6910 | 3.500 |
Why?
|
| Depressive Disorder, Major | 23 | 2024 | 4745 | 2.970 |
Why?
|
| Prenatal Exposure Delayed Effects | 18 | 2023 | 2496 | 2.530 |
Why?
|
| Psychotic Disorders | 24 | 2023 | 3193 | 2.100 |
Why?
|
| Stress, Psychological | 18 | 2024 | 4455 | 1.870 |
Why?
|
| Menopause | 7 | 2024 | 1639 | 1.810 |
Why?
|
| Growth Differentiation Factors | 5 | 2023 | 99 | 1.760 |
Why?
|
| Schizophrenic Psychology | 34 | 2016 | 1646 | 1.530 |
Why?
|
| Hypothalamus | 10 | 2021 | 998 | 1.510 |
Why?
|
| Brain | 54 | 2024 | 26947 | 1.490 |
Why?
|
| Sex Factors | 36 | 2024 | 10504 | 1.440 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2018 | 699 | 1.420 |
Why?
|
| Affective Disorders, Psychotic | 7 | 2017 | 186 | 1.330 |
Why?
|
| Memory | 7 | 2024 | 2179 | 1.290 |
Why?
|
| Prefrontal Cortex | 16 | 2019 | 2209 | 1.240 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2023 | 841 | 1.200 |
Why?
|
| Pituitary-Adrenal System | 7 | 2018 | 551 | 1.170 |
Why?
|
| Hydrocortisone | 9 | 2024 | 1802 | 1.120 |
Why?
|
| Magnetic Resonance Imaging | 68 | 2024 | 36284 | 1.120 |
Why?
|
| Estradiol | 8 | 2019 | 1933 | 1.040 |
Why?
|
| Aging | 9 | 2024 | 8650 | 1.030 |
Why?
|
| Neuropsychological Tests | 37 | 2024 | 7021 | 1.010 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2021 | 224 | 1.000 |
Why?
|
| Memory, Short-Term | 10 | 2019 | 978 | 0.970 |
Why?
|
| Amygdala | 11 | 2020 | 1350 | 0.970 |
Why?
|
| Brain Mapping | 28 | 2021 | 6570 | 0.930 |
Why?
|
| Gene Deletion | 3 | 2019 | 2666 | 0.890 |
Why?
|
| Androgens | 3 | 2020 | 1291 | 0.890 |
Why?
|
| NFATC Transcription Factors | 2 | 2015 | 381 | 0.830 |
Why?
|
| Affect | 6 | 2017 | 1480 | 0.830 |
Why?
|
| Anorexia Nervosa | 5 | 2015 | 1361 | 0.820 |
Why?
|
| Verbal Learning | 5 | 2017 | 462 | 0.820 |
Why?
|
| Hippocampus | 13 | 2020 | 3736 | 0.790 |
Why?
|
| Satiation | 2 | 2012 | 83 | 0.790 |
Why?
|
| Cerebral Cortex | 10 | 2024 | 5759 | 0.770 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 582 | 0.750 |
Why?
|
| Female | 178 | 2024 | 390323 | 0.740 |
Why?
|
| Reward | 8 | 2024 | 965 | 0.730 |
Why?
|
| Hunger | 3 | 2013 | 206 | 0.730 |
Why?
|
| Progesterone | 5 | 2014 | 742 | 0.710 |
Why?
|
| Cytokines | 5 | 2021 | 7338 | 0.710 |
Why?
|
| Male | 157 | 2024 | 358747 | 0.640 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2019 | 240 | 0.620 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 126 | 0.600 |
Why?
|
| Skin | 3 | 2019 | 4464 | 0.600 |
Why?
|
| Hair Follicle | 3 | 2015 | 210 | 0.590 |
Why?
|
| Adult | 138 | 2024 | 219935 | 0.590 |
Why?
|
| Schizophrenic Language | 3 | 2006 | 57 | 0.580 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2024 | 1132 | 0.580 |
Why?
|
| Pregnancy Complications | 7 | 2016 | 2942 | 0.570 |
Why?
|
| Gyrus Cinguli | 9 | 2024 | 1115 | 0.560 |
Why?
|
| Menstrual Cycle | 4 | 2010 | 536 | 0.560 |
Why?
|
| Bipolar Disorder | 9 | 2021 | 5079 | 0.550 |
Why?
|
| Fetal Hypoxia | 2 | 2011 | 30 | 0.550 |
Why?
|
| Dibenzothiazepines | 6 | 2003 | 102 | 0.550 |
Why?
|
| Family Health | 5 | 2012 | 1257 | 0.550 |
Why?
|
| Ghrelin | 2 | 2018 | 251 | 0.540 |
Why?
|
| Pregnancy | 30 | 2023 | 29742 | 0.540 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 463 | 0.540 |
Why?
|
| Leukocytes | 1 | 2024 | 2025 | 0.540 |
Why?
|
| Humans | 206 | 2024 | 758406 | 0.520 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 597 | 0.520 |
Why?
|
| Antipsychotic Agents | 11 | 2015 | 3060 | 0.510 |
Why?
|
| Adult Children | 1 | 2016 | 103 | 0.510 |
Why?
|
| Practice Management, Dental | 3 | 2002 | 17 | 0.510 |
Why?
|
| Language Disorders | 2 | 2006 | 138 | 0.510 |
Why?
|
| Cognition | 7 | 2024 | 6953 | 0.510 |
Why?
|
| Neural Pathways | 11 | 2024 | 3039 | 0.500 |
Why?
|
| Food Preferences | 2 | 2018 | 399 | 0.480 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2018 | 8945 | 0.480 |
Why?
|
| Genome | 2 | 2019 | 1739 | 0.460 |
Why?
|
| Dependovirus | 1 | 2019 | 711 | 0.460 |
Why?
|
| Cognition Disorders | 11 | 2017 | 3975 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2021 | 17768 | 0.450 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2047 | 0.440 |
Why?
|
| Hypothalamic Hormones | 2 | 2013 | 145 | 0.440 |
Why?
|
| Intelligence | 5 | 2018 | 921 | 0.430 |
Why?
|
| Pituitary Hormones | 2 | 2013 | 182 | 0.430 |
Why?
|
| New England | 8 | 2020 | 1053 | 0.430 |
Why?
|
| Calcineurin | 1 | 2014 | 229 | 0.430 |
Why?
|
| Prenatal Care | 1 | 2020 | 1129 | 0.420 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3384 | 0.410 |
Why?
|
| Extinction, Psychological | 3 | 2011 | 371 | 0.410 |
Why?
|
| Lactation | 1 | 2014 | 397 | 0.390 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 2690 | 0.390 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 682 | 0.390 |
Why?
|
| Prader-Willi Syndrome | 1 | 2011 | 76 | 0.370 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15399 | 0.370 |
Why?
|
| Fetal Development | 2 | 2013 | 766 | 0.360 |
Why?
|
| Young Adult | 44 | 2024 | 58808 | 0.360 |
Why?
|
| Maternal Exposure | 2 | 2017 | 1045 | 0.360 |
Why?
|
| Multipotent Stem Cells | 1 | 2012 | 200 | 0.360 |
Why?
|
| Stress, Physiological | 2 | 2016 | 1398 | 0.350 |
Why?
|
| Middle Aged | 73 | 2024 | 219568 | 0.340 |
Why?
|
| Psychiatric Status Rating Scales | 23 | 2016 | 6013 | 0.340 |
Why?
|
| Nerve Net | 6 | 2024 | 2263 | 0.340 |
Why?
|
| Myasthenia Gravis | 3 | 2001 | 212 | 0.340 |
Why?
|
| Men | 1 | 2010 | 65 | 0.340 |
Why?
|
| Biomedical Research | 4 | 2021 | 3418 | 0.340 |
Why?
|
| Women | 2 | 2010 | 225 | 0.330 |
Why?
|
| Appetite | 4 | 2018 | 247 | 0.320 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 952 | 0.320 |
Why?
|
| Energy Intake | 3 | 2021 | 2127 | 0.320 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2019 | 529 | 0.310 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 345 | 0.310 |
Why?
|
| Myostatin | 2 | 2023 | 126 | 0.310 |
Why?
|
| Case-Control Studies | 19 | 2024 | 22029 | 0.310 |
Why?
|
| Motivation | 3 | 2015 | 1996 | 0.310 |
Why?
|
| Weight Gain | 2 | 2020 | 2346 | 0.310 |
Why?
|
| Perinatal Care | 1 | 2011 | 242 | 0.310 |
Why?
|
| Alleles | 1 | 2019 | 6895 | 0.310 |
Why?
|
| Conditioning, Classical | 2 | 2011 | 365 | 0.310 |
Why?
|
| Photic Stimulation | 6 | 2014 | 1967 | 0.300 |
Why?
|
| Depression | 9 | 2021 | 8057 | 0.300 |
Why?
|
| Memory Disorders | 5 | 2024 | 1197 | 0.300 |
Why?
|
| Hormones | 2 | 2014 | 869 | 0.290 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1878 | 0.290 |
Why?
|
| Fear | 3 | 2011 | 1462 | 0.280 |
Why?
|
| Child Development | 5 | 2020 | 2285 | 0.280 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 697 | 0.280 |
Why?
|
| Frontal Lobe | 7 | 2019 | 1419 | 0.270 |
Why?
|
| Acoustic Stimulation | 3 | 2012 | 1232 | 0.270 |
Why?
|
| Mental Recall | 5 | 2017 | 1208 | 0.260 |
Why?
|
| Oxygen | 9 | 2017 | 4191 | 0.260 |
Why?
|
| Obesity | 4 | 2021 | 12870 | 0.260 |
Why?
|
| Arousal | 4 | 2012 | 1157 | 0.260 |
Why?
|
| Haloperidol | 4 | 2003 | 388 | 0.260 |
Why?
|
| Corpus Callosum | 3 | 2016 | 749 | 0.260 |
Why?
|
| Corpus Striatum | 4 | 2024 | 1233 | 0.260 |
Why?
|
| Mothers | 5 | 2021 | 2189 | 0.250 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2005 | 50 | 0.250 |
Why?
|
| Limbic System | 5 | 2019 | 419 | 0.250 |
Why?
|
| Postprandial Period | 5 | 2013 | 314 | 0.250 |
Why?
|
| Hypertension | 2 | 2022 | 8499 | 0.250 |
Why?
|
| Pirenzepine | 2 | 2002 | 116 | 0.250 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 221 | 0.240 |
Why?
|
| Event-Related Potentials, P300 | 3 | 2014 | 149 | 0.240 |
Why?
|
| Reproduction | 2 | 2019 | 646 | 0.240 |
Why?
|
| Stem Cells | 2 | 2015 | 3521 | 0.240 |
Why?
|
| England | 2 | 2023 | 524 | 0.240 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2016 | 3339 | 0.230 |
Why?
|
| Schizotypal Personality Disorder | 4 | 2003 | 290 | 0.230 |
Why?
|
| Diffusion Tensor Imaging | 8 | 2019 | 2386 | 0.230 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 8544 | 0.230 |
Why?
|
| Brain Stem | 2 | 2020 | 857 | 0.230 |
Why?
|
| Temporal Lobe | 6 | 2014 | 1688 | 0.230 |
Why?
|
| Interpersonal Relations | 4 | 2013 | 1433 | 0.230 |
Why?
|
| Weight Loss | 3 | 2021 | 2671 | 0.230 |
Why?
|
| Attention | 8 | 2014 | 2387 | 0.230 |
Why?
|
| Risk Factors | 22 | 2023 | 73809 | 0.220 |
Why?
|
| Anxiety | 7 | 2021 | 4539 | 0.220 |
Why?
|
| Adolescent | 41 | 2024 | 87892 | 0.220 |
Why?
|
| Research Design | 2 | 2018 | 6157 | 0.220 |
Why?
|
| Comorbidity | 5 | 2021 | 10495 | 0.220 |
Why?
|
| Feeding Behavior | 5 | 2021 | 3184 | 0.210 |
Why?
|
| Receptors, Opioid, mu | 1 | 2024 | 166 | 0.210 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2024 | 138 | 0.210 |
Why?
|
| Women's Health | 3 | 2020 | 2057 | 0.200 |
Why?
|
| Gonads | 2 | 2016 | 109 | 0.200 |
Why?
|
| Functional Laterality | 7 | 2006 | 2253 | 0.200 |
Why?
|
| Psychomotor Performance | 4 | 2014 | 1878 | 0.200 |
Why?
|
| Dental Enamel | 1 | 2021 | 60 | 0.190 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11471 | 0.190 |
Why?
|
| Rhode Island | 3 | 2011 | 349 | 0.190 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.190 |
Why?
|
| Intelligence Tests | 4 | 2015 | 500 | 0.190 |
Why?
|
| Executive Function | 2 | 2022 | 1374 | 0.190 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2020 | 170 | 0.180 |
Why?
|
| Parahippocampal Gyrus | 2 | 2016 | 115 | 0.180 |
Why?
|
| Life Change Events | 1 | 2005 | 953 | 0.180 |
Why?
|
| Animals | 23 | 2023 | 167768 | 0.180 |
Why?
|
| Keratinocytes | 2 | 2015 | 790 | 0.170 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2359 | 0.170 |
Why?
|
| Parents | 2 | 2013 | 3548 | 0.170 |
Why?
|
| Men's Health | 1 | 2020 | 73 | 0.170 |
Why?
|
| Delusions | 4 | 2015 | 298 | 0.170 |
Why?
|
| Cohort Studies | 18 | 2020 | 41256 | 0.170 |
Why?
|
| Cholinergic Antagonists | 1 | 2000 | 164 | 0.170 |
Why?
|
| Mood Disorders | 1 | 2006 | 1124 | 0.170 |
Why?
|
| Vagus Nerve | 2 | 2020 | 458 | 0.170 |
Why?
|
| Bone Development | 1 | 2023 | 472 | 0.170 |
Why?
|
| Dental Staff | 1 | 1999 | 14 | 0.170 |
Why?
|
| Mice, Inbred mdx | 1 | 2019 | 88 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3533 | 0.160 |
Why?
|
| Gender Identity | 3 | 2018 | 757 | 0.160 |
Why?
|
| Task Performance and Analysis | 5 | 2016 | 759 | 0.160 |
Why?
|
| Child Behavior Disorders | 2 | 2017 | 805 | 0.160 |
Why?
|
| Risk | 10 | 2019 | 9599 | 0.160 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 14490 | 0.160 |
Why?
|
| Postmenopause | 2 | 2018 | 2509 | 0.160 |
Why?
|
| Reminder Systems | 1 | 2002 | 387 | 0.160 |
Why?
|
| Oxytocin | 2 | 2013 | 401 | 0.160 |
Why?
|
| Employee Performance Appraisal | 1 | 1999 | 86 | 0.160 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 261 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5797 | 0.160 |
Why?
|
| Child of Impaired Parents | 2 | 2013 | 459 | 0.150 |
Why?
|
| Telomere | 1 | 2024 | 931 | 0.150 |
Why?
|
| Appointments and Schedules | 1 | 2002 | 441 | 0.150 |
Why?
|
| Hyperphagia | 1 | 2018 | 139 | 0.150 |
Why?
|
| Tryptophan | 1 | 2019 | 479 | 0.150 |
Why?
|
| Social Environment | 4 | 1992 | 1023 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2014 | 23342 | 0.150 |
Why?
|
| Brain Chemistry | 1 | 2001 | 959 | 0.150 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 666 | 0.150 |
Why?
|
| Age Factors | 13 | 2019 | 18358 | 0.150 |
Why?
|
| Prolactin | 2 | 2014 | 621 | 0.140 |
Why?
|
| Women's Health Services | 1 | 2017 | 89 | 0.140 |
Why?
|
| Demyelinating Diseases | 2 | 1997 | 351 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14354 | 0.140 |
Why?
|
| Mental Disorders | 6 | 2020 | 6803 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 516 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2019 | 554 | 0.140 |
Why?
|
| Polyradiculoneuropathy | 1 | 1996 | 65 | 0.140 |
Why?
|
| Heart Rate | 3 | 2020 | 4166 | 0.140 |
Why?
|
| Child | 21 | 2021 | 79818 | 0.130 |
Why?
|
| Military Personnel | 1 | 2005 | 1244 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2003 | 1141 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 1996 | 121 | 0.130 |
Why?
|
| Gonadotropins | 1 | 2017 | 241 | 0.130 |
Why?
|
| Factor Analysis, Statistical | 3 | 2016 | 999 | 0.130 |
Why?
|
| Language Tests | 2 | 2006 | 190 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 58 | 0.130 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2015 | 35 | 0.130 |
Why?
|
| Food | 2 | 2018 | 771 | 0.130 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1527 | 0.130 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 146 | 0.130 |
Why?
|
| Dominance, Cerebral | 4 | 2006 | 622 | 0.130 |
Why?
|
| Caudate Nucleus | 2 | 2016 | 389 | 0.130 |
Why?
|
| Maternal Age | 1 | 2018 | 807 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 2125 | 0.130 |
Why?
|
| Myelin Sheath | 1 | 2019 | 652 | 0.130 |
Why?
|
| Learning | 3 | 2024 | 1739 | 0.120 |
Why?
|
| Phonetics | 2 | 2006 | 198 | 0.120 |
Why?
|
| Psychological Tests | 2 | 2017 | 639 | 0.120 |
Why?
|
| Socioeconomic Factors | 5 | 2018 | 7818 | 0.120 |
Why?
|
| Analysis of Variance | 10 | 2016 | 6234 | 0.120 |
Why?
|
| Mice | 10 | 2023 | 81101 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1788 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2018 | 696 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 699 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2019 | 820 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 617 | 0.120 |
Why?
|
| Papilloma | 1 | 2015 | 141 | 0.120 |
Why?
|
| Gastrectomy | 1 | 2019 | 670 | 0.120 |
Why?
|
| Rest | 1 | 2019 | 914 | 0.120 |
Why?
|
| Prospective Studies | 11 | 2023 | 54137 | 0.120 |
Why?
|
| Receptors, Prolactin | 1 | 2014 | 16 | 0.120 |
Why?
|
| Premenopause | 1 | 2018 | 1038 | 0.120 |
Why?
|
| Social Adjustment | 4 | 2010 | 632 | 0.120 |
Why?
|
| Acylation | 1 | 2014 | 97 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 818 | 0.120 |
Why?
|
| Interleukin-10 | 2 | 2018 | 1174 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2012 | 748 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 2057 | 0.120 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 660 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1167 | 0.110 |
Why?
|
| Parietal Lobe | 3 | 2013 | 849 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 1203 | 0.110 |
Why?
|
| Cross-Sectional Studies | 9 | 2018 | 25956 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 22003 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2019 | 933 | 0.110 |
Why?
|
| Family | 5 | 2007 | 3188 | 0.110 |
Why?
|
| Reference Values | 8 | 2006 | 4919 | 0.110 |
Why?
|
| Respiration | 1 | 2020 | 1654 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 263 | 0.110 |
Why?
|
| Sex Chromosomes | 1 | 2013 | 101 | 0.110 |
Why?
|
| Fathers | 3 | 2011 | 377 | 0.110 |
Why?
|
| Carcinogens | 1 | 2015 | 451 | 0.110 |
Why?
|
| Infant, Newborn | 5 | 2020 | 26183 | 0.110 |
Why?
|
| Child, Preschool | 11 | 2020 | 42062 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 818 | 0.110 |
Why?
|
| Spinal Stenosis | 1 | 1996 | 262 | 0.110 |
Why?
|
| Sex Differentiation | 2 | 2006 | 73 | 0.110 |
Why?
|
| Phenotype | 9 | 2021 | 16534 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2021 | 1185 | 0.110 |
Why?
|
| Thalamus | 4 | 2007 | 1040 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 955 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 269 | 0.110 |
Why?
|
| Anorexia | 1 | 2013 | 154 | 0.110 |
Why?
|
| Janus Kinases | 1 | 2014 | 249 | 0.110 |
Why?
|
| Birth Injuries | 3 | 2015 | 150 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 1995 | 416 | 0.100 |
Why?
|
| Ligands | 1 | 2019 | 3258 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1365 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2015 | 914 | 0.100 |
Why?
|
| Anisotropy | 5 | 2015 | 1278 | 0.100 |
Why?
|
| Semantics | 2 | 2006 | 599 | 0.100 |
Why?
|
| Parvalbumins | 1 | 2014 | 260 | 0.100 |
Why?
|
| Electroencephalography | 5 | 2014 | 6187 | 0.100 |
Why?
|
| Pilot Projects | 6 | 2018 | 8553 | 0.100 |
Why?
|
| Birth Weight | 1 | 2020 | 2097 | 0.100 |
Why?
|
| Psychophysics | 3 | 2011 | 289 | 0.100 |
Why?
|
| Steroids | 1 | 2017 | 926 | 0.100 |
Why?
|
| Testosterone | 2 | 2014 | 2471 | 0.100 |
Why?
|
| Infant | 7 | 2017 | 36055 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2018 | 2322 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 15773 | 0.100 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 415 | 0.100 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 368 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12604 | 0.100 |
Why?
|
| Publishing | 1 | 1998 | 833 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2014 | 777 | 0.090 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 340 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1401 | 0.090 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 188 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2012 | 194 | 0.090 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 986 | 0.090 |
Why?
|
| Environment | 2 | 2010 | 1118 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 503 | 0.090 |
Why?
|
| Glycemic Index | 1 | 2013 | 393 | 0.090 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15785 | 0.090 |
Why?
|
| Residential Facilities | 1 | 1990 | 42 | 0.090 |
Why?
|
| Follow-Up Studies | 15 | 2019 | 39059 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4342 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1655 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2019 | 2612 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1486 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 249 | 0.080 |
Why?
|
| Logistic Models | 3 | 2015 | 13276 | 0.080 |
Why?
|
| Paternal Age | 1 | 2009 | 87 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2015 | 719 | 0.080 |
Why?
|
| Cerebellar Ataxia | 1 | 1990 | 149 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2024 | 3759 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 1277 | 0.080 |
Why?
|
| Caregivers | 1 | 2021 | 2225 | 0.080 |
Why?
|
| Aged | 24 | 2017 | 168218 | 0.080 |
Why?
|
| Prevalence | 3 | 2018 | 15651 | 0.080 |
Why?
|
| Melanocytes | 1 | 2012 | 509 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2850 | 0.080 |
Why?
|
| Cadherins | 1 | 2012 | 898 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3593 | 0.080 |
Why?
|
| Organ Size | 4 | 2018 | 2252 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4902 | 0.070 |
Why?
|
| Incidence | 4 | 2018 | 21272 | 0.070 |
Why?
|
| Aminolevulinic Acid | 1 | 2008 | 142 | 0.070 |
Why?
|
| Boston | 2 | 2011 | 9304 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2004 | 2026 | 0.070 |
Why?
|
| Atrophy | 3 | 2003 | 1627 | 0.070 |
Why?
|
| Housing | 2 | 1990 | 666 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2751 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2018 | 5070 | 0.070 |
Why?
|
| Cell Movement | 1 | 2019 | 5201 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 1999 | 0.070 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 1997 | 708 | 0.070 |
Why?
|
| Social Support | 4 | 1990 | 2155 | 0.070 |
Why?
|
| Ambulatory Care | 3 | 2006 | 2768 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2731 | 0.070 |
Why?
|
| Clozapine | 3 | 2002 | 506 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3090 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 18940 | 0.070 |
Why?
|
| Brain Edema | 1 | 1990 | 603 | 0.070 |
Why?
|
| Avoidance Learning | 2 | 2005 | 248 | 0.060 |
Why?
|
| Linguistics | 1 | 2006 | 106 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2439 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2015 | 2782 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 791 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1647 | 0.060 |
Why?
|
| Adipocytes | 1 | 2012 | 1177 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5331 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3602 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2020 | 12876 | 0.060 |
Why?
|
| Perinatology | 1 | 2004 | 62 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1504 | 0.060 |
Why?
|
| Age of Onset | 4 | 2015 | 3298 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1520 | 0.060 |
Why?
|
| Disease Progression | 3 | 2019 | 13468 | 0.060 |
Why?
|
| Neurons | 3 | 2014 | 9416 | 0.060 |
Why?
|
| Emotions | 3 | 2021 | 2734 | 0.060 |
Why?
|
| Body Weight | 2 | 2012 | 4603 | 0.060 |
Why?
|
| Myelin Proteins | 2 | 1994 | 208 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2010 | 994 | 0.050 |
Why?
|
| Chronic Disease | 9 | 2014 | 9267 | 0.050 |
Why?
|
| Verbal Behavior | 2 | 2004 | 335 | 0.050 |
Why?
|
| Parabiosis | 1 | 2023 | 64 | 0.050 |
Why?
|
| Lead | 1 | 2008 | 878 | 0.050 |
Why?
|
| Dementia | 1 | 2017 | 2650 | 0.050 |
Why?
|
| Double-Blind Method | 6 | 1996 | 12262 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 701 | 0.050 |
Why?
|
| Hostility | 1 | 2003 | 183 | 0.050 |
Why?
|
| Tourette Syndrome | 2 | 1996 | 395 | 0.050 |
Why?
|
| Linear Models | 3 | 2007 | 5862 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 2 | 1994 | 102 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1610 | 0.050 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 75 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2023 | 1958 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2004 | 461 | 0.050 |
Why?
|
| MicroRNAs | 2 | 2014 | 3783 | 0.050 |
Why?
|
| Nuclear Family | 2 | 2004 | 313 | 0.050 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 20055 | 0.050 |
Why?
|
| Eating | 2 | 2021 | 1536 | 0.050 |
Why?
|
| Mental Fatigue | 1 | 2000 | 22 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2284 | 0.050 |
Why?
|
| Psychomotor Agitation | 1 | 2003 | 304 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 12096 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 2000 | 157 | 0.040 |
Why?
|
| Risperidone | 1 | 2002 | 379 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2000 | 93 | 0.040 |
Why?
|
| Tegmentum Mesencephali | 1 | 1980 | 59 | 0.040 |
Why?
|
| Gait | 2 | 2015 | 812 | 0.040 |
Why?
|
| Patient Readmission | 4 | 1989 | 3261 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9404 | 0.040 |
Why?
|
| Receptors, Cholinergic | 1 | 2000 | 241 | 0.040 |
Why?
|
| Markov Chains | 2 | 2018 | 965 | 0.040 |
Why?
|
| Quality of Life | 1 | 2001 | 13285 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2467 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 1980 | 85 | 0.040 |
Why?
|
| Algorithms | 5 | 2018 | 13961 | 0.040 |
Why?
|
| Benzodiazepines | 2 | 2002 | 1130 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2020 | 175 | 0.040 |
Why?
|
| Personnel Management | 1 | 1999 | 52 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9460 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2003 | 4048 | 0.040 |
Why?
|
| Time Factors | 3 | 2012 | 39872 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2013 | 6346 | 0.040 |
Why?
|
| Acute Disease | 3 | 2016 | 7225 | 0.040 |
Why?
|
| Efficiency | 1 | 2002 | 477 | 0.040 |
Why?
|
| Retrospective Studies | 12 | 2018 | 80168 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 868 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2007 | 3701 | 0.040 |
Why?
|
| Auditory Perception | 2 | 2004 | 580 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10718 | 0.040 |
Why?
|
| Volition | 1 | 1998 | 62 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 1990 | 1694 | 0.040 |
Why?
|
| Sulfoglycosphingolipids | 1 | 1997 | 18 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2019 | 64378 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 402 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 373 | 0.040 |
Why?
|
| Psychometrics | 5 | 2010 | 3052 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 1980 | 365 | 0.040 |
Why?
|
| Odds Ratio | 4 | 2015 | 9650 | 0.040 |
Why?
|
| Apomorphine | 2 | 1993 | 149 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3754 | 0.040 |
Why?
|
| Concept Formation | 1 | 1998 | 160 | 0.030 |
Why?
|
| Vocabulary | 1 | 1997 | 165 | 0.030 |
Why?
|
| Amino Acids | 1 | 2023 | 1713 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2018 | 236 | 0.030 |
Why?
|
| Substance-Related Disorders | 2 | 2010 | 4402 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 890 | 0.030 |
Why?
|
| Antibodies | 2 | 1994 | 2420 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11892 | 0.030 |
Why?
|
| Immunoglobulin M | 3 | 1997 | 1529 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 82 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 1997 | 278 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2017 | 255 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2015 | 207 | 0.030 |
Why?
|
| Smell | 1 | 1997 | 259 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 29915 | 0.030 |
Why?
|
| Seasons | 2 | 1992 | 1519 | 0.030 |
Why?
|
| Aggression | 1 | 1980 | 745 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2000 | 859 | 0.030 |
Why?
|
| Horses | 1 | 2015 | 298 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1077 | 0.030 |
Why?
|
| Fertility | 1 | 2019 | 773 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 1955 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 2629 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 1996 | 291 | 0.030 |
Why?
|
| Lymphocytosis | 1 | 1995 | 119 | 0.030 |
Why?
|
| Community Mental Health Services | 2 | 1990 | 392 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 208 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1996 | 555 | 0.030 |
Why?
|
| Rats | 4 | 2015 | 23679 | 0.030 |
Why?
|
| Naloxone | 1 | 1977 | 369 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1988 | 3867 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2001 | 6354 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15225 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 1988 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1256 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2013 | 109 | 0.030 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2013 | 114 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2210 | 0.030 |
Why?
|
| Interview, Psychological | 2 | 2014 | 809 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1441 | 0.030 |
Why?
|
| Hallucinations | 1 | 2015 | 366 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 197 | 0.030 |
Why?
|
| Attitude | 2 | 1988 | 777 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 550 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 996 | 0.030 |
Why?
|
| Visual Perception | 1 | 2000 | 1374 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 320 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2204 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1489 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1993 | 304 | 0.020 |
Why?
|
| Amphetamine | 1 | 1993 | 224 | 0.020 |
Why?
|
| Metagenome | 1 | 2015 | 450 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1256 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 1997 | 939 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2014 | 598 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 495 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 1993 | 350 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8143 | 0.020 |
Why?
|
| Propionates | 1 | 2011 | 182 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1994 | 459 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 899 | 0.020 |
Why?
|
| Dopamine | 2 | 1993 | 1599 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 272 | 0.020 |
Why?
|
| Software | 2 | 2016 | 4415 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 719 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1993 | 1263 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 802 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1192 | 0.020 |
Why?
|
| Personality Development | 1 | 1990 | 244 | 0.020 |
Why?
|
| United States | 4 | 2015 | 72136 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2012 | 1018 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1268 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1167 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1632 | 0.020 |
Why?
|
| Depressive Disorder | 2 | 1993 | 3727 | 0.020 |
Why?
|
| Diffusion | 1 | 2011 | 813 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2010 | 359 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1347 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 585 | 0.020 |
Why?
|
| Social Behavior | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 1988 | 48 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2006 | 1732 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 932 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2010 | 650 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1997 | 2118 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 1788 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2194 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3208 | 0.020 |
Why?
|
| Aftercare | 2 | 1985 | 910 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2012 | 530 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1996 | 10748 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 6457 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 1998 | 1462 | 0.020 |
Why?
|
| Phenols | 1 | 2011 | 514 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2019 | 3047 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1573 | 0.020 |
Why?
|
| Occupations | 1 | 2009 | 515 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3858 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 957 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1995 | 2201 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 1599 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 2825 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58683 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 1988 | 285 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2000 | 23884 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2685 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 2385 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6363 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 2772 | 0.020 |
Why?
|
| Action Potentials | 1 | 1993 | 1816 | 0.020 |
Why?
|
| Gadolinium | 1 | 1990 | 959 | 0.020 |
Why?
|
| Family Characteristics | 1 | 1990 | 1000 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2018 | 6201 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 374 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1994 | 1489 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2006 | 12440 | 0.020 |
Why?
|
| Galvanic Skin Response | 1 | 2006 | 348 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1988 | 494 | 0.010 |
Why?
|
| Communication | 1 | 1999 | 3846 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2020 | 8451 | 0.010 |
Why?
|
| Cerebral Ventricles | 2 | 1997 | 542 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2009 | 697 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 1870 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 1994 | 107 | 0.010 |
Why?
|
| Prognosis | 2 | 2019 | 29557 | 0.010 |
Why?
|
| Achievement | 1 | 2006 | 289 | 0.010 |
Why?
|
| Leptin | 1 | 2012 | 1591 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 707 | 0.010 |
Why?
|
| Premature Birth | 1 | 2015 | 1771 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3432 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 283 | 0.010 |
Why?
|
| Deinstitutionalization | 1 | 1983 | 20 | 0.010 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12945 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 7583 | 0.010 |
Why?
|
| Alcoholism | 1 | 1993 | 1962 | 0.010 |
Why?
|
| Length of Stay | 2 | 1988 | 6439 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3714 | 0.010 |
Why?
|
| Suicide | 1 | 1993 | 1599 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1993 | 2714 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8426 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2002 | 123 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 2002 | 143 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14641 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1651 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1988 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 1990 | 2058 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1567 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5721 | 0.010 |
Why?
|
| Maternal Welfare | 1 | 2000 | 112 | 0.010 |
Why?
|
| Radiography | 2 | 2004 | 6954 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2010 | 2880 | 0.010 |
Why?
|
| Geniculate Bodies | 1 | 1980 | 154 | 0.010 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 84 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 3801 | 0.010 |
Why?
|
| Cats | 1 | 1980 | 976 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9468 | 0.010 |
Why?
|
| Personality Tests | 1 | 1997 | 81 | 0.010 |
Why?
|
| Massachusetts | 1 | 1990 | 8823 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2004 | 2676 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1997 | 257 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1977 | 135 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1977 | 134 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1980 | 589 | 0.010 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1996 | 165 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2004 | 1757 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 1977 | 308 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1995 | 105 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 3563 | 0.010 |
Why?
|
| Reading | 1 | 1998 | 529 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1998 | 987 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1985 | 2685 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1980 | 1036 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2907 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3322 | 0.010 |
Why?
|
| Tic Disorders | 1 | 1994 | 136 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3561 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20500 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 7985 | 0.010 |
Why?
|
| Species Specificity | 1 | 1977 | 2417 | 0.010 |
Why?
|
| Ataxia | 1 | 1994 | 305 | 0.010 |
Why?
|
| Reaction Time | 1 | 1998 | 2075 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 1994 | 236 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1985 | 3433 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18119 | 0.010 |
Why?
|
| Hospitalization | 1 | 1990 | 10652 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1994 | 664 | 0.010 |
Why?
|
| Germany, West | 1 | 1989 | 13 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2551 | 0.010 |
Why?
|
| Antigens | 1 | 1994 | 1445 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 6036 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 5031 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 10146 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1996 | 3441 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1994 | 1541 | 0.000 |
Why?
|
| Histones | 1 | 1994 | 2577 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11070 | 0.000 |
Why?
|
| Biopsy | 1 | 1995 | 6768 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1998 | 7980 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1994 | 2044 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 4406 | 0.000 |
Why?
|